Japan's health ministry has decided to reform its clinical drug trial procedures to enable pharmaceutical companies to swiftly initiate trials to examine the efficacy and safety of new drugs, ...
ESTERO, FL / ACCESS Newswire / November 26, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, ...
Globally, metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common chronic liver disease, affecting up to one in three people in the general population, with an ...
An injection that blocks the activity of a protein involved in aging reverses naturally occurring cartilage loss in the knee ...
Scientists have identified a potential new treatment strategy for Alzheimer’s disease using a combination of two existing cancer drugs. The research suggests that targeting multiple types of brain ...
Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics ...
Three cancer therapies were among the first two batches of drugs to receive vouchers through a new FDA program.
The Veterans With ALS Reporting Act seeks to develop strategies for lowering the potential risks for ALS, commonly known as ...
In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.
Sibeprenlimab, a monoclonal antibody, is the only IgA nephropathy treatment option to selectively inhibit the activity of a ...
Researchers at Stanford found a way to cure or prevent Type 1 diabetes in mice using a combined blood stem cell and islet ...
A recent WHO report outlined concerning changes in the antibacterial pipeline — namely, that the pipeline is shrinking and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback